We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Ebola Vaccine Progress and Shortfalls Highlighted

News   Aug 14, 2018 | Original Story from the National Institutes of Health.

 
Ebola Vaccine Progress and Shortfalls Highlighted

Study volunteer receives an inoculation at Redemption Hospital in Monrovia, Liberia on the opening day of PREVAC, a Phase 2 Ebola vaccine trial in West Africa. Credit: NIAID.

 
 
 

RELATED ARTICLES

Significant Flaws in Forensics Software

News

Significant flaws have been identified in recently released forensic software designed to assess the age of individuals based on their skeletal remains, with predicted ages off by 14 years on average.

READ MORE

97.7% of Hospital Pathogens Eliminated by UV Light Disinfection

News

Using UV disinfection technology to reduce the risk of hospital-acquired infections eliminated up to 97.7 % of pathogens in operating rooms.

READ MORE

Another Piece of Ebola Virus Puzzle

News

Researchers have discovered the interaction between an Ebola virus protein and a protein in human cells that may be an important key to unlocking the pathway of replication of the killer disease in human hosts.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE